Table 1.
Minimum inhibitory concentrations (MIC) of oxacillin (μg/mL) against staphylococcal strains isolated from DBRACL and CLAR bioaerosols
| Sampling site | Staphylococci isolates | MIC of Oxacillin (μg/mL) | Susceptibilitya | ||
|---|---|---|---|---|---|
| Susceptible (%) | Resistance (%) | ||||
| DBRACL | Human associated | S. haemolyticus(n=5) | < 0.5-4 | 3 (60) | 2 (40) |
| S. cohnii(n=4) | < 0.5-2 | 1 (25) | 3 (75) | ||
| S. hominis(n=4) | < 0.5-16 | 3 (75) | 1 (25) | ||
| S. epidermidis(n=1) | < 0.5 | 1 (100) | 0 (0) | ||
| S. warneri(n=1) | < 0.5 | 1 (100) | 0 (0) | ||
| S. saprophyticus(n=1) | 1 | 0 (0) | 1 (100) | ||
| Animal associated | S. xylosus(n=4) | < 0.5-1 | 2 (50) | 2 (50) | |
| S. lentus(n=2) | < 0.5 | 1 (50) | 1 (50) | ||
| CLAR | Human associated | S. hominis(n=5) | 1-8 | 0 (0) | 5 (100) |
| S. capitis(n=4) | <0.5-1 | 2 (50) | 2 (50) | ||
| S. epidermidis(n=4) | <0.5-8 | 2 (50) | 2 (50) | ||
| S. aureus(n=2) | 1-8 | 1 (50) | 1 (50) | ||
| S. warneri(n=1) | 1 | 0 (0) | 1 (100) | ||
| Animal associated | S. xylosus(n=12) | <0.5- 32 | 4 (33.3) | 8 (66.7) | |
| S. lentus(n=4) | <0.5-1 | 3 (75) | 1 (25) | ||
| S. sciuri(n=3) | 1 | 0 (0) | 3 (100) | ||
a For CNS: Susceptible (MIC ≤0.25 μg/mL); Resistant (MIC ≥0.5 μg/mL) and For S. aureus: Susceptible (MIC ≤2 μg/mL); Resistant (MIC ≥4 μg/mL)